BioPharmX (BPMX) Awarded U.S. Patent Protection for Novel Tetracycline-class Topical Drug Compositions
Tweet Send to a Friend
BioPharmX Corporation (NYSE: BPMX), a specialty pharmaceutical company developing products for the dermatology market, today announced the U.S. Patent and ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
